ZimVie Inc (ZIMV)
15.80
-0.03
(-0.19%)
USD |
NASDAQ |
May 03, 16:00
15.79
-0.01
(-0.06%)
After-Hours: 20:00
ZimVie SG&A Expense (Quarterly): -124.84M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -124.84M |
| September 30, 2023 | 117.35M |
| June 30, 2023 | 128.48M |
| March 31, 2023 | 127.97M |
| December 31, 2022 | -136.35M |
| September 30, 2022 | 129.34M |
| June 30, 2022 | 126.05M |
| Date | Value |
|---|---|
| March 31, 2022 | 134.11M |
| December 31, 2021 | -197.49M |
| September 30, 2021 | 135.99M |
| June 30, 2021 | 139.99M |
| March 31, 2021 | 129.08M |
| December 31, 2020 | 142.34M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
-197.49M
Minimum
Dec 2021
142.34M
Maximum
Dec 2020
65.54M
Average
128.48M
Median
Jun 2023
SG&A Expense (Quarterly) Benchmarks
| Orthofix Medical Inc | 132.28M |
| Stryker Corp | 1.84B |
| Globus Medical Inc | 244.72M |
| Paragon 28 Inc | 48.25M |
| Perspective Therapeutics Inc | 1.694M |